Form D · Pharmaceuticals
Waterstone Pharmaceuticals Inc.
Wuhan, Hubei Province, F4 · CIK 0001555787
Offering snapshot reported Sep 26, 2012 · SEC filing
- Reported sold
- $19M Offering amount: $20M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 12, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 26, 2012 | Initial | $19,000,000 | No comparison | 5 | SEC filing |
| Aug 21, 2012 | Initial | $3,392,121 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184656
Source: Form D, filed Sep 26, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Faming Zhang | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Biolake B3 4, No. 666 Gaoxin Road Eastlake, National High Tech Development
Wuhan, Hubei Province, F4, 430074
Wuhan, Hubei Province, F4, 430074